Spec­trum Labs is­sues world­wide re­call of ep­i­neph­rine in­gre­di­ent

Three lots of ac­tive phar­ma­ceu­ti­cal in­gre­di­ents used in the emer­gency med­i­cine ep­i­neph­rine are be­ing vol­un­tar­i­ly re­called by the man­u­fac­tur­er.

Spec­trum Lab­o­ra­to­ry Prod­ucts sent out a world­wide vol­un­tary re­call for the lots of ep­i­neph­rine USP, a bulk API pow­der used to man­u­fac­ture the pre­scrip­tion prod­uct. Ac­cord­ing to the FDA no­tice, the main com­plaints have found the prod­uct to be “dis­col­ored.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.